Please Wait.....
Report
Biodefense - A Global Market Overview
Market Report I 2024-09-23 I 255 Pages I Industry Experts
Biodefense Market Trends and Outlook
Biodefense refers to a comprehensive strategy to safeguard against biological threats, including bioterrorism, biological warfare agents, and emerging infectious diseases. It encompasses a range of actions aimed at preventing, detecting, and responding to biological attacks or outbreaks. These actions include developing and deploying medical countermeasures like vaccines and therapeutics, enhancing surveillance systems, implementing biosecurity measures, and establishing emergency response protocols. Biodefense aims to reduce the impact of biological agents and ensure readiness for potential biological emergencies. This requires collaboration among bioscience labs, hospitals, customs, and public health sectors to prevent the use of dangerous pathogens and toxins.
The global Biodefense market is estimated at US$18.2 billion in 2024 and is anticipated to register a CAGR of 8.6% during the 2024-2030 analysis period and stand at a projected US$29.9 billion by 2030.
The Biodefense market is driven by technological advancements, rising global health hazards, and substantial government investments. Key drivers include the rapid development of next-generation vaccines and treatments; with artificial intelligence (AI) and machine learning (ML) enhancing early detection and response systems; advances in biodetection technology and point-of-care diagnostics improve outbreak response and early warning capabilities; biosecurity measures are strengthening research facilities and high-risk sectors to prevent pathogen spread; collaborative efforts between governments, academia, and businesses accelerate R&D and technology transfer; and increased government funding, prompted by the threats of bioterrorism and pandemics, fuels market expansion. The COVID-19 pandemic has heightened awareness of healthcare vulnerabilities, driving a focus on bio-surveillance, vaccine development, and emergency response mechanisms. Climate change and global travel increase zoonotic disease risks, further fueling market growth.
Biodefense Regional Market Analysis
In 2024, North America, led by the U.S., dominated the biodefense market with a 46% share due to significant government investment, robust R&D capabilities, and a strong emphasis on national security. The U.S. government's initiatives, such as the BioShield Act, and the presence of major industry players have bolstered this position. Conversely, the Asia Pacific region is poised to grow rapidly, with a forecast CAGR of 10.5% from 2024-2030, driven by increased R&D investments and rising biothreat incidents. Countries like China, India, Japan, and South Korea are enhancing biodefense capabilities and investing heavily in public health preparedness, making the Asia Pacific the fastest-growing market segment.
Biodefense Market Analysis by Product Type
The anthrax segment leads the market, holding a notable share of 27.8% in 2024. This is attributed to its significant public health impact and ease of dispersion. Anthrax, caused by the Bacillus anthracis bacterium, poses a major bioterrorism threat due to its spore form, which can endure lengthy periods in the environment and spread easily. This segment sees substantial investments in vaccines and countermeasures, driven by past bioterrorism events and ongoing concerns. On the other hand, the "Other Products" segment, which includes diseases such as Influenza, Viral Hemorrhagic Fevers, Ebola, Zika, and others, is expected to grow the fastest with a CAGR of 10.5% from 2024 to 2030. This rapid growth is propelled by the recent rise in infections and the development of new vaccines and treatments for diseases like Zika, Ebola, and Nipah as companies strive to tackle these emerging threats.
Biodefense Market Analysis by Application
The Military segment is projected to hold the largest market share at 64.5% in 2024, driven by substantial government investment in advanced technologies, research, and medical countermeasures to protect national security. The high perceived risk of biological threats and the strategic importance of military preparedness drive extensive funding and development efforts, ensuring robust defenses against potential bioterrorism and biological attacks. Conversely, the Civilian segment is expected to grow rapidly with a CAGR of 9.1% from 2024 to 2030, due to rising biological threats from terrorist organizations. This growth reflects heightened government efforts and research focused on protecting civilians from potential biological attacks and emerging viruses.
Biodefense Market Analysis by End-User
The hospitals and clinics segment dominates the biodefense market with a 47.1% share in 2024 and is projected to record the fastest CAGR of 9.2% from 2024-2030. This is due to their critical role in managing and treating biological attacks, requiring advanced infrastructure, protective equipment, and diagnostic tools. Their capacity to handle mass casualties and enhance biodefense preparedness drives their dominant market position. The 'Other End Users' segment, which includes research organizations, biotechnology firms, and government agencies, is experiencing significant market growth driven by increased investment in biodefense research and development, leading to robust performance.
Biodefense Market Report Scope
This global report on Biodefense analyzes the market based on product, application, and end users. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.
Key Metrics
Historical Period: 2021-2023
Base Year: 2023
Forecast Period: 2024-2030
Units: Value market in US$
Companies Mentioned: 15+
Biodefense Market by Geographic Region
- North America (The United States, Canada, and Mexico)
- Europe (Germany, France, The United Kingdom, Spain, Italy, and Rest of Europe)
- Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, and Rest of South America)
- Rest of World
Biodefense Market by Product
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others (Including Influenza, Plague, Cholera, Food Poisoning, Viral Hemorrhagic Fevers, Brucellosis, Glanders, Melioidosis, Tularemia, Viral Encephalitis, Ebola Virus, Zica Virus, Nipah Virus, and Hantavirus)
Biodefense Market by Application
- Military
- Civilian
Biodefense Market by End User
- Hospitals and Clinics
- Ambulatory Care Centers
- Other End Users (Including Research Organizations, Pharmaceutical and Biopharmaceutical Companies, Government Agencies, and Emergency Responders)
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
- Product Outline
- Biodefense Defined
- Biodefense Products
o Anthrax
o Smallpox
o Botulism
o Radiation/Nuclear
o Other Products
- Biodefense Applications
o Military
o Civilian
- Biodefense End Users
o Hospitals and Clinics
o Ambulatory Care Centers
o Other End Users
2. Key Market Trends
3. Key Global Players
- Alnylam Pharmaceuticals Inc
- Altimmune Inc
- Bavarian Nordic
- Dynavax Technologies Corporation
- Dynport Vaccine Company
- Elusys Therapeutics
- Emergent Biosolutions
- GlaxoSmithKline (UK)
- Ichor Medical Systems
- Ology Bioservices
- Sanofi
- SIGA Technologies
- Soligenix
- Statera BioPharma, Inc.
- Xoma Corporation
4. Key Business & Product Trends
5. Global Market Overview
- Global Biodefense Market Overview by Product
o Biodefense Product Type Market Overview by Global Region
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Other Products
- Global Biodefense Market Overview by Application
o Biodefense Application Market Overview by Global Region
- Military
- Civilian
- Global Biodefense Market Overview by End User
o Biodefense End User Market Overview by Global Region
- Hospitals and Clinics
- Ambulatory Care Centers
- Other End Users
PART B: REGIONAL MARKET PERSPECTIVE
- Global Biodefense Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
6. North America
- North American Biodefense Market Overview by Geographic Region
- North American Biodefense Market Overview by Product
- North American Biodefense Market Overview by Application
- North American Biodefense Market Overview by End User
- Country-wise Analysis of North American Biodefense Market
o The United States
- United States Biodefense Market Overview by Product
- United States Biodefense Market Overview by Application
- United States Biodefense Market Overview by End User
o Canada
- Canadian Biodefense Market Overview by Product
- Canadian Biodefense Market Overview by Application
- Canadian Biodefense Market Overview by End User
o Mexico
- Mexican Biodefense Market Overview by Product
- Mexican Biodefense Market Overview by Application
- Mexican Biodefense Market Overview by End User
7. Europe
- European Biodefense Market Overview by Geographic Region
- European Biodefense Market Overview by Product
- European Biodefense Market Overview by Application
- European Biodefense Market Overview by End User
- Country-wise Analysis of European Biodefense Market
o Germany
- German Biodefense Market Overview by Product
- German Biodefense Market Overview by Application
- German Biodefense Market Overview by End User
o France
- French Biodefense Market Overview by Product
- French Biodefense Market Overview by Application
- French Biodefense Market Overview by End User
o The United Kingdom
- United Kingdom Biodefense Market Overview by Product
- United Kingdom Biodefense Market Overview by Application
- United Kingdom Biodefense Market Overview by End User
o Spain
- Spanish Biodefense Market Overview by Product
- Spanish Biodefense Market Overview by Application
- Spanish Biodefense Market Overview by End User
o Italy
- Italian Biodefense Market Overview by Product
- Italian Biodefense Market Overview by Application
- Italian Biodefense Market Overview by End User
o Rest of Europe
- Rest of Europe Biodefense Market Overview by Product
- Rest of Europe Biodefense Market Overview by Application
- Rest of Europe Biodefense Market Overview by End User
8. Asia-Pacific
- Asia-Pacific Biodefense Market Overview by Geographic Region
- Asia-Pacific Biodefense Market Overview by Product
- Asia-Pacific Biodefense Market Overview by Application
- Asia-Pacific Biodefense Market Overview by End User
- Country-wise Analysis of Asia-Pacific Biodefense Market
o Japan
- Japanese Biodefense Market Overview by Product
- Japanese Biodefense Market Overview by Application
- Japanese Biodefense Market Overview by End User
o China
- Chinese Biodefense Market Overview by Product
- Chinese Biodefense Market Overview by Application
- Chinese Biodefense Market Overview by End User
o India
- Indian Biodefense Market Overview by Product
- Indian Biodefense Market Overview by Application
- Indian Biodefense Market Overview by End User
o South Korea
- South Korean Biodefense Market Overview by Product
- South Korean Biodefense Market Overview by Application
- South Korean Biodefense Market Overview by End User
o Rest of Asia-Pacific
- Rest of Asia-Pacific Biodefense Market Overview by Product
- Rest of Asia-Pacific Biodefense Market Overview by Application
- Rest of Asia-Pacific Biodefense Market Overview by End User
9. South America
- South American Biodefense Market Overview by Geographic Region
- South American Biodefense Market Overview by Product
- South American Biodefense Market Overview by Application
- South American Biodefense Market Overview by End User
- Country-wise Analysis of Asia-Pacific Biodefense Market
o Brazil
- Brazilian Biodefense Market Overview by Product
- Brazilian Biodefense Market Overview by Application
- Brazilian Biodefense Market Overview by End User
o Argentina
- Argentine Biodefense Market Overview by Product
- Argentine Biodefense Market Overview by Application
- Argentine Biodefense Market Overview by End User
o Rest of South America
- Rest of South American Biodefense Market Overview by Product
- Rest of South American Biodefense Market Overview by Application
- Rest of South American Biodefense Market Overview by End User
10. Rest of World
- Rest of World Biodefense Market Overview by Product
- Rest of World Biodefense Market Overview by Application
- Rest of World Biodefense Market Overview by End User
PART C: GUIDE TO THE INDUSTRY
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security